Advertisement

HindustanTimes Sat,20 Dec 2014

20-40% cut in insulin prices

Himani Chandna Gurtoo, Hindustan Times  New Delhi, January 01, 2013
First Published: 23:54 IST(1/1/2013) | Last Updated: 23:59 IST(1/1/2013)

Daily insulin shots for diabetics are pinching less as pricing regulator National Pharmaceutical Pricing Authority (NPPA) slashed the price of the blood sugar-controlling products by 25% to 40% in November.

Advertisement

India has a Rs. 1,500-crore insulin market, which caters for 12 million insulin-reliant patients.

A 10ml vial, which lasts for 10 to 12 days for an average patient, now costs around Rs. 284 against Rs. 369 two months ago. Insulin is among 74 drugs whose prices the government controls.

The lowest prices of the largest selling imported and domestic insulin brands are now considered to be ceilings in the respective categories. Besides, NPPA clamped down on arbitrary cost adjustments by firms.

“These are two different steps aimed at bringing down the retail prices of insulin,” CP Singh, chairman, NPPA, told HT.

DG Shah, director general of industry body Indian Pharmaceutical Alliances, however, said, “The move may benefit the consumer in the short term, but it may discourage firms to expand capacities and enter the market.”


Advertisement
more from New Delhi

Delhi: Schools on alert after Peshawar

The terror attack that killed over 130 students in Pakistan’s Peshawar has jolted city schools into taking all possible measures to tighten security in and around their campus. Many schools reported a drop in attendance after the attack.
Advertisement
Most Popular
Advertisement
Advertisement
Copyright © 2014 HT Media Limited. All Rights Reserved